CAMG
PFE icon

CWA Asset Management Group’s Pfizer PFE Stock Holding History

CWA Asset Management Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
99,813
+11,713
+13% +$306K 0.07% 250
2026
Q1 		$2.47M Buy
88,100
+52,061
+144% +$1.39M 0.08% 230
2025
Q4 		$897K Buy
36,039
+4,277
+13% +$108K 0.03% 373
2025
Q3 		$809K Buy
31,762
+5,422
+21% +$134K 0.03% 396
2025
Q2 		$638K Sell
26,340
-5,844
-18% -$136K 0.03% 414
2025
Q1 		$816K Buy
32,184
+1,225
+4% +$32.1K 0.04% 333
2024
Q4 		$821K Sell
30,959
-16,783
-35% -$455K 0.04% 293
2024
Q3 		$1.38M Buy
+47,742
New +$1.39M 0.07% 198
2024
Q1 		$1.21M Sell
43,647
-129,644
-75% -$3.6M 0.07% 196
2023
Q4 		$4.99M Sell
173,291
-179,648
-51% -$5.43M 0.34% 73
2023
Q3 		$11.7M Sell
352,939
-12,077
-3% -$427K 0.86% 33
2023
Q2 		$13.4M Buy
365,016
+16,299
+5% +$634K 0.92% 29
2023
Q1 		$14.2M Buy
348,717
+7,564
+2% +$327K 1.06% 24
2022
Q4 		$17.5M Buy
341,153
+14,105
+4% +$676K 1.42% 13
2022
Q3 		$14.3M Buy
327,048
+7,925
+2% +$385K 1.38% 19
2022
Q2 		$16.7M Buy
319,123
+8,480
+3% +$432K 1.56% 16
2022
Q1 		$16.1M Sell
310,643
-79,126
-20% -$4.11M 1.23% 21
2021
Q4 		$23M Buy
389,769
+5,852
+2% +$290K 1.7% 14
2021
Q3 		$16.5M Buy
383,917
+70,523
+23% +$3.12M 1.31% 21
2021
Q2 		$12.4M Buy
313,394
+27,182
+9% +$1.06M 1.01% 29
2021
Q1 		$10.4M Buy
286,212
+38,829
+16% +$1.38M 0.95% 33
2020
Q4 		$9.11M Buy
247,383
+16,043
+7% +$588K 0.95% 30
2020
Q3 		$8.05M Buy
231,340
+44,208
+24% +$1.55M 1.08% 27
2020
Q2 		$5.81M Sell
187,132
-7,788
-4% -$265K 1.02% 30
2020
Q1 		$6.04M Buy
194,920
+36,923
+23% +$1.26M 1.15% 27
2019
Q4 		$5.87M Buy
157,997
+5,513
+4% +$196K 0.95% 34
2019
Q3 		$5.2M Buy
152,484
+18,819
+14% +$684K 0.83% 41
2019
Q2 		$5.49M Buy
133,665
+11,370
+9% +$451K 0.94% 30
2019
Q1 		$4.93M Buy
122,295
+3,381
+3% +$135K 0.95% 30
2018
Q4 		$4.92M Buy
118,914
+3,348
+3% +$139K 1.15% 25
2018
Q3 		$4.83M Sell
115,566
-2,330
-2% -$89.7K 1.07% 29
2018
Q2 		$4.06M Buy
117,896
+2,584
+2% +$88.3K 0.95% 36
2018
Q1 		$3.88M Buy
115,312
+21,651
+23% +$744K 0.96% 36
2017
Q4 		$3.22M Buy
93,661
+8,877
+10% +$303K 0.85% 44
2017
Q3 		$2.87M Buy
84,784
+5,683
+7% +$183K 0.84% 46
2017
Q2 		$2.52M Buy
79,101
+10,509
+15% +$331K 0.8% 50
2017
Q1 		$2.23M Buy
68,592
+13,012
+23% +$410K 0.76% 48
2016
Q4 		$1.71M Buy
55,580
+15,579
+39% +$476K 0.73% 46
2016
Q3 		$1.29M Buy
40,001
+3,746
+10% +$125K 0.71% 45
2016
Q2 		$1.21M Buy
36,255
+6,913
+24% +$221K 0.74% 44
2016
Q1 		$825K Buy
29,342
+8,632
+42% +$247K 0.84% 43
2015
Q4 		$634K Buy
+20,710
New +$652K 0.71% 50

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

CWA Asset Management Group's PFE Position: Q2 2026 in Review

CWA Asset Management Group increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $306K and bringing the position to 99,813 shares worth $2.4M. The position accounts for 0.07% of the portfolio, ranked #250.

CWA Asset Management Group first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $23M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • CWA Asset Management Group held 99,813 shares of Pfizer worth $2.4M as of Q2 2026.
  • CWA Asset Management Group bought 11,713 Pfizer shares in Q2 2026, an estimated $306K.
  • Pfizer made up 0.07% of CWA Asset Management Group's portfolio in Q2 2026, its #250 holding.
  • CWA Asset Management Group first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • CWA Asset Management Group's Pfizer position peaked at $23M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.